Novo Nordisk
NVO
NVO
1,504 hedge funds and large institutions have $33.4B invested in Novo Nordisk in 2023 Q4 according to their latest regulatory filings, with 287 funds opening new positions, 579 increasing their positions, 442 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
16% more funds holding
Funds holding: 1,302 → 1,504 (+202)
11% more funds holding in top 10
Funds holding in top 10: 62 → 69 (+7)
0.57% more ownership
Funds ownership: 8.74% → 9.31% (+0.57%)
Holders
1,504
Holding in Top 10
69
Calls
$719M
Puts
$596M
Top Buyers
| 1 | +$1.24B | |
| 2 | +$391M | |
| 3 | +$277M | |
| 4 |
Amundi
Paris,
France
|
+$145M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$134M |
Top Sellers
| 1 | -$246M | |
| 2 | -$239M | |
| 3 | -$92.2M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$82.8M |
| 5 |
BlackRock
New York
|
-$78M |